Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1459
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation ; volume:265 ; number:5 ; day:6 ; month:3 ; year:2018 ; pages:1115-1122 ; date:5.2018
Journal of neurology ; 265, Heft 5 (6.3.2018), 1115-1122, 5.2018
- Creator
-
Tallantyre, E. C.
- Contributor
-
Whittam, D. H.
Jolles, S.
Paling, D.
Constantinesecu, C.
Robertson, N. P.
Jacob, A.
SpringerLink (Online service)
- DOI
-
10.1007/s00415-018-8812-0
- URN
-
urn:nbn:de:101:1-2018070722453097630612
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tallantyre, E. C.
- Whittam, D. H.
- Jolles, S.
- Paling, D.
- Constantinesecu, C.
- Robertson, N. P.
- Jacob, A.
- SpringerLink (Online service)
Other Objects (12)
Correction to: Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation
A novel glycosylated anti-CD20 monoclonal antibody from transgenic cattle
Genetics of primary antibody deficiency
Adiponectin deficiency accelerates brain aging via mitochondria-associated neuroinflammation
Enhanced efficacy of gemcitabine in combination with anti-CD20 monoclonal antibody against CD20+ non-Hodgkin's lymphoma cell lines in vitro and in scidmice
The CD20-specific engineered toxin antibody MT-3724 exhibits lethal effects against mantle cell lymphoma
Prolonged viral pneumonia and high mortality in COVID-19 patients on anti-CD20 monoclonal antibody therapy
Pharmakokinetik des monoklonalen anti-CD20 Antikörpers Rituximab bei aggressiven CD20 positiven B-Zell-Lymphomen
α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses
α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses
Regeneration of the immunoglobulin heavy-chain repertoire after transient B-cell depletion with an anti-CD20 antibody
Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages
Correction to: Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation
A novel glycosylated anti-CD20 monoclonal antibody from transgenic cattle
Genetics of primary antibody deficiency
Adiponectin deficiency accelerates brain aging via mitochondria-associated neuroinflammation
Enhanced efficacy of gemcitabine in combination with anti-CD20 monoclonal antibody against CD20+ non-Hodgkin's lymphoma cell lines in vitro and in scidmice
The CD20-specific engineered toxin antibody MT-3724 exhibits lethal effects against mantle cell lymphoma
Prolonged viral pneumonia and high mortality in COVID-19 patients on anti-CD20 monoclonal antibody therapy
Pharmakokinetik des monoklonalen anti-CD20 Antikörpers Rituximab bei aggressiven CD20 positiven B-Zell-Lymphomen
α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses
α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses
Regeneration of the immunoglobulin heavy-chain repertoire after transient B-cell depletion with an anti-CD20 antibody
Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophages
Correction to: Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation
A novel glycosylated anti-CD20 monoclonal antibody from transgenic cattle
Genetics of primary antibody deficiency
Adiponectin deficiency accelerates brain aging via mitochondria-associated neuroinflammation
Enhanced efficacy of gemcitabine in combination with anti-CD20 monoclonal antibody against CD20+ non-Hodgkin's lymphoma cell lines in vitro and in scidmice
The CD20-specific engineered toxin antibody MT-3724 exhibits lethal effects against mantle cell lymphoma
Prolonged viral pneumonia and high mortality in COVID-19 patients on anti-CD20 monoclonal antibody therapy
Pharmakokinetik des monoklonalen anti-CD20 Antikörpers Rituximab bei aggressiven CD20 positiven B-Zell-Lymphomen
α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses
α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses
Regeneration of the immunoglobulin heavy-chain repertoire after transient B-cell depletion with an anti-CD20 antibody